nodes	percent_of_prediction	percent_of_DWPC	metapath
Eszopiclone—Breast neoplasm—Octreotide—thymus cancer	0.04	0.0425	CcSEcCtD
Eszopiclone—Ulcerative stomatitis—Octreotide—thymus cancer	0.0261	0.0278	CcSEcCtD
Eszopiclone—Hernia—Octreotide—thymus cancer	0.0257	0.0274	CcSEcCtD
Eszopiclone—Renal pain—Octreotide—thymus cancer	0.023	0.0244	CcSEcCtD
Eszopiclone—Pregnancy—Octreotide—thymus cancer	0.0213	0.0226	CcSEcCtD
Eszopiclone—Cholelithiasis—Octreotide—thymus cancer	0.0194	0.0206	CcSEcCtD
Eszopiclone—Galactorrhoea—Octreotide—thymus cancer	0.0186	0.0198	CcSEcCtD
Eszopiclone—Neuralgia—Octreotide—thymus cancer	0.0174	0.0185	CcSEcCtD
Eszopiclone—Metrorrhagia—Octreotide—thymus cancer	0.0169	0.018	CcSEcCtD
Eszopiclone—Neuritis—Octreotide—thymus cancer	0.0162	0.0172	CcSEcCtD
Eszopiclone—Herpes zoster—Octreotide—thymus cancer	0.016	0.017	CcSEcCtD
Eszopiclone—Otitis media—Octreotide—thymus cancer	0.0155	0.0165	CcSEcCtD
Eszopiclone—Tingling sensation—Octreotide—thymus cancer	0.015	0.016	CcSEcCtD
Eszopiclone—Nephrolithiasis—Octreotide—thymus cancer	0.015	0.016	CcSEcCtD
Eszopiclone—Numbness—Octreotide—thymus cancer	0.0146	0.0155	CcSEcCtD
Eszopiclone—Sensory loss—Octreotide—thymus cancer	0.0139	0.0148	CcSEcCtD
Eszopiclone—Breast pain—Octreotide—thymus cancer	0.0138	0.0147	CcSEcCtD
Eszopiclone—Amenorrhoea—Octreotide—thymus cancer	0.0137	0.0146	CcSEcCtD
Eszopiclone—Viral infection—Octreotide—thymus cancer	0.0134	0.0142	CcSEcCtD
Eszopiclone—Rectal haemorrhage—Octreotide—thymus cancer	0.0134	0.0142	CcSEcCtD
Eszopiclone—Arthropathy—Octreotide—thymus cancer	0.0133	0.0141	CcSEcCtD
Eszopiclone—Cellulitis—Octreotide—thymus cancer	0.0133	0.0141	CcSEcCtD
Eszopiclone—Muscle twitching—Octreotide—thymus cancer	0.0123	0.0131	CcSEcCtD
Eszopiclone—Vaginal inflammation—Octreotide—thymus cancer	0.0121	0.0128	CcSEcCtD
Eszopiclone—Cystitis noninfective—Octreotide—thymus cancer	0.0118	0.0125	CcSEcCtD
Eszopiclone—Cystitis—Octreotide—thymus cancer	0.0117	0.0124	CcSEcCtD
Eszopiclone—Vaginal infection—Octreotide—thymus cancer	0.0114	0.0121	CcSEcCtD
Eszopiclone—Neuropathy—Octreotide—thymus cancer	0.0113	0.012	CcSEcCtD
Eszopiclone—Cramps of lower extremities—Octreotide—thymus cancer	0.0111	0.0118	CcSEcCtD
Eszopiclone—Bladder pain—Octreotide—thymus cancer	0.0109	0.0116	CcSEcCtD
Eszopiclone—Mouth ulceration—Octreotide—thymus cancer	0.0109	0.0116	CcSEcCtD
Eszopiclone—Gynaecomastia—Octreotide—thymus cancer	0.0108	0.0115	CcSEcCtD
Eszopiclone—Thrombophlebitis—Octreotide—thymus cancer	0.0101	0.0108	CcSEcCtD
Eszopiclone—Injury—Octreotide—thymus cancer	0.00953	0.0101	CcSEcCtD
Eszopiclone—Amnesia—Octreotide—thymus cancer	0.00933	0.00991	CcSEcCtD
Eszopiclone—Arthritis—Octreotide—thymus cancer	0.00902	0.00958	CcSEcCtD
Eszopiclone—Osteoarthritis—Octreotide—thymus cancer	0.00876	0.00931	CcSEcCtD
Eszopiclone—Irritability—Octreotide—thymus cancer	0.00836	0.00889	CcSEcCtD
Eszopiclone—Dehydration—Octreotide—thymus cancer	0.00815	0.00866	CcSEcCtD
Eszopiclone—Dry skin—Octreotide—thymus cancer	0.00803	0.00854	CcSEcCtD
Eszopiclone—Cramp muscle—Octreotide—thymus cancer	0.00789	0.00839	CcSEcCtD
Eszopiclone—Gastritis—Octreotide—thymus cancer	0.00776	0.00824	CcSEcCtD
Eszopiclone—Muscular weakness—Octreotide—thymus cancer	0.00773	0.00821	CcSEcCtD
Eszopiclone—Influenza—Octreotide—thymus cancer	0.00757	0.00805	CcSEcCtD
Eszopiclone—Asthma—Octreotide—thymus cancer	0.00757	0.00805	CcSEcCtD
Eszopiclone—Bronchitis—Octreotide—thymus cancer	0.00728	0.00774	CcSEcCtD
Eszopiclone—Dysuria—Octreotide—thymus cancer	0.00708	0.00753	CcSEcCtD
Eszopiclone—Pollakiuria—Octreotide—thymus cancer	0.007	0.00744	CcSEcCtD
Eszopiclone—Weight increased—Octreotide—thymus cancer	0.00689	0.00733	CcSEcCtD
Eszopiclone—Weight decreased—Octreotide—thymus cancer	0.00685	0.00728	CcSEcCtD
Eszopiclone—Drowsiness—Octreotide—thymus cancer	0.00675	0.00718	CcSEcCtD
Eszopiclone—Depression—Octreotide—thymus cancer	0.00673	0.00716	CcSEcCtD
Eszopiclone—Neuropathy peripheral—Octreotide—thymus cancer	0.00662	0.00704	CcSEcCtD
Eszopiclone—Conjunctivitis—Octreotide—thymus cancer	0.00656	0.00698	CcSEcCtD
Eszopiclone—Urinary tract infection—Octreotide—thymus cancer	0.00656	0.00698	CcSEcCtD
Eszopiclone—Haematuria—Octreotide—thymus cancer	0.00644	0.00684	CcSEcCtD
Eszopiclone—Epistaxis—Octreotide—thymus cancer	0.00637	0.00677	CcSEcCtD
Eszopiclone—Rhinitis—Octreotide—thymus cancer	0.00608	0.00646	CcSEcCtD
Eszopiclone—Hepatitis—Octreotide—thymus cancer	0.00606	0.00644	CcSEcCtD
Eszopiclone—Hypoaesthesia—Octreotide—thymus cancer	0.00603	0.00641	CcSEcCtD
Eszopiclone—Pharyngitis—Octreotide—thymus cancer	0.00602	0.0064	CcSEcCtD
Eszopiclone—Oedema peripheral—Octreotide—thymus cancer	0.00597	0.00635	CcSEcCtD
Eszopiclone—GABRA3—neck—thymus cancer	0.0057	0.0964	CbGeAlD
Eszopiclone—Tinnitus—Octreotide—thymus cancer	0.00565	0.00601	CcSEcCtD
Eszopiclone—Alopecia—Octreotide—thymus cancer	0.00536	0.00569	CcSEcCtD
Eszopiclone—Tension—Octreotide—thymus cancer	0.00518	0.0055	CcSEcCtD
Eszopiclone—Nervousness—Octreotide—thymus cancer	0.00513	0.00545	CcSEcCtD
Eszopiclone—Back pain—Octreotide—thymus cancer	0.0051	0.00543	CcSEcCtD
Eszopiclone—Muscle spasms—Octreotide—thymus cancer	0.00507	0.00539	CcSEcCtD
Eszopiclone—Vision blurred—Octreotide—thymus cancer	0.00497	0.00529	CcSEcCtD
Eszopiclone—Tremor—Octreotide—thymus cancer	0.00494	0.00526	CcSEcCtD
Eszopiclone—Ill-defined disorder—Octreotide—thymus cancer	0.0049	0.0052	CcSEcCtD
Eszopiclone—Anaemia—Octreotide—thymus cancer	0.00488	0.00518	CcSEcCtD
Eszopiclone—Agitation—Octreotide—thymus cancer	0.00485	0.00515	CcSEcCtD
Eszopiclone—Malaise—Octreotide—thymus cancer	0.00476	0.00506	CcSEcCtD
Eszopiclone—Vertigo—Octreotide—thymus cancer	0.00474	0.00504	CcSEcCtD
Eszopiclone—Palpitations—Octreotide—thymus cancer	0.00466	0.00496	CcSEcCtD
Eszopiclone—Convulsion—Octreotide—thymus cancer	0.00457	0.00486	CcSEcCtD
Eszopiclone—Hypertension—Octreotide—thymus cancer	0.00456	0.00484	CcSEcCtD
Eszopiclone—Chest pain—Octreotide—thymus cancer	0.00449	0.00478	CcSEcCtD
Eszopiclone—Myalgia—Octreotide—thymus cancer	0.00449	0.00478	CcSEcCtD
Eszopiclone—Anxiety—Octreotide—thymus cancer	0.00448	0.00476	CcSEcCtD
Eszopiclone—Discomfort—Octreotide—thymus cancer	0.00444	0.00472	CcSEcCtD
Eszopiclone—GABRG3—pituitary gland—thymus cancer	0.00439	0.0744	CbGeAlD
Eszopiclone—Dry mouth—Octreotide—thymus cancer	0.00439	0.00467	CcSEcCtD
Eszopiclone—Anaphylactic shock—Octreotide—thymus cancer	0.00431	0.00458	CcSEcCtD
Eszopiclone—Infection—Octreotide—thymus cancer	0.00428	0.00455	CcSEcCtD
Eszopiclone—Tachycardia—Octreotide—thymus cancer	0.0042	0.00447	CcSEcCtD
Eszopiclone—Hyperhidrosis—Octreotide—thymus cancer	0.00416	0.00443	CcSEcCtD
Eszopiclone—Anorexia—Octreotide—thymus cancer	0.00411	0.00436	CcSEcCtD
Eszopiclone—TSPO—neck—thymus cancer	0.00393	0.0664	CbGeAlD
Eszopiclone—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00392	0.00417	CcSEcCtD
Eszopiclone—Insomnia—Octreotide—thymus cancer	0.0039	0.00414	CcSEcCtD
Eszopiclone—Paraesthesia—Octreotide—thymus cancer	0.00387	0.00411	CcSEcCtD
Eszopiclone—Dyspnoea—Octreotide—thymus cancer	0.00384	0.00408	CcSEcCtD
Eszopiclone—Somnolence—Octreotide—thymus cancer	0.00383	0.00407	CcSEcCtD
Eszopiclone—Dyspepsia—Octreotide—thymus cancer	0.00379	0.00403	CcSEcCtD
Eszopiclone—Decreased appetite—Octreotide—thymus cancer	0.00374	0.00398	CcSEcCtD
Eszopiclone—Gastrointestinal disorder—Octreotide—thymus cancer	0.00372	0.00395	CcSEcCtD
Eszopiclone—Fatigue—Octreotide—thymus cancer	0.00371	0.00395	CcSEcCtD
Eszopiclone—Pain—Octreotide—thymus cancer	0.00368	0.00391	CcSEcCtD
Eszopiclone—Constipation—Octreotide—thymus cancer	0.00368	0.00391	CcSEcCtD
Eszopiclone—Feeling abnormal—Octreotide—thymus cancer	0.00355	0.00377	CcSEcCtD
Eszopiclone—Gastrointestinal pain—Octreotide—thymus cancer	0.00352	0.00374	CcSEcCtD
Eszopiclone—Urticaria—Octreotide—thymus cancer	0.00342	0.00364	CcSEcCtD
Eszopiclone—Abdominal pain—Octreotide—thymus cancer	0.0034	0.00362	CcSEcCtD
Eszopiclone—Body temperature increased—Octreotide—thymus cancer	0.0034	0.00362	CcSEcCtD
Eszopiclone—Hypersensitivity—Octreotide—thymus cancer	0.00317	0.00337	CcSEcCtD
Eszopiclone—Asthenia—Octreotide—thymus cancer	0.00309	0.00328	CcSEcCtD
Eszopiclone—GABRA4—pituitary gland—thymus cancer	0.00307	0.0519	CbGeAlD
Eszopiclone—Pruritus—Octreotide—thymus cancer	0.00305	0.00324	CcSEcCtD
Eszopiclone—Diarrhoea—Octreotide—thymus cancer	0.00295	0.00313	CcSEcCtD
Eszopiclone—TSPO—hematopoietic system—thymus cancer	0.00292	0.0495	CbGeAlD
Eszopiclone—Dizziness—Octreotide—thymus cancer	0.00285	0.00303	CcSEcCtD
Eszopiclone—Vomiting—Octreotide—thymus cancer	0.00274	0.00291	CcSEcCtD
Eszopiclone—Rash—Octreotide—thymus cancer	0.00272	0.00289	CcSEcCtD
Eszopiclone—Dermatitis—Octreotide—thymus cancer	0.00271	0.00288	CcSEcCtD
Eszopiclone—GABRA3—thyroid gland—thymus cancer	0.00271	0.0459	CbGeAlD
Eszopiclone—Headache—Octreotide—thymus cancer	0.0027	0.00287	CcSEcCtD
Eszopiclone—TSPO—epithelium—thymus cancer	0.00267	0.0452	CbGeAlD
Eszopiclone—GABRG2—pituitary gland—thymus cancer	0.00256	0.0434	CbGeAlD
Eszopiclone—Nausea—Octreotide—thymus cancer	0.00256	0.00272	CcSEcCtD
Eszopiclone—TSPO—cardiac atrium—thymus cancer	0.00222	0.0376	CbGeAlD
Eszopiclone—TSPO—pituitary gland—thymus cancer	0.00217	0.0367	CbGeAlD
Eszopiclone—TSPO—lymphoid tissue—thymus cancer	0.00206	0.0348	CbGeAlD
Eszopiclone—GABRB2—lung—thymus cancer	0.00201	0.034	CbGeAlD
Eszopiclone—CYP2C8—hematopoietic system—thymus cancer	0.00201	0.0339	CbGeAlD
Eszopiclone—TSPO—bone marrow—thymus cancer	0.00187	0.0317	CbGeAlD
Eszopiclone—TSPO—thyroid gland—thymus cancer	0.00187	0.0316	CbGeAlD
Eszopiclone—CYP2C9—hematopoietic system—thymus cancer	0.00178	0.0301	CbGeAlD
Eszopiclone—TSPO—lung—thymus cancer	0.0017	0.0287	CbGeAlD
Eszopiclone—PTGS1—hematopoietic system—thymus cancer	0.00163	0.0275	CbGeAlD
Eszopiclone—CYP2C8—pituitary gland—thymus cancer	0.00149	0.0252	CbGeAlD
Eszopiclone—PTGS1—epithelium—thymus cancer	0.00149	0.0252	CbGeAlD
Eszopiclone—CYP3A4—hematopoietic system—thymus cancer	0.00136	0.023	CbGeAlD
Eszopiclone—GABRA2—lymph node—thymus cancer	0.00125	0.0212	CbGeAlD
Eszopiclone—PTGS1—cardiac atrium—thymus cancer	0.00124	0.0209	CbGeAlD
Eszopiclone—PTGS1—pituitary gland—thymus cancer	0.00121	0.0204	CbGeAlD
Eszopiclone—TSPO—lymph node—thymus cancer	0.00116	0.0196	CbGeAlD
Eszopiclone—PTGS1—thyroid gland—thymus cancer	0.00104	0.0176	CbGeAlD
Eszopiclone—PTGS1—lung—thymus cancer	0.000945	0.016	CbGeAlD
Eszopiclone—PTGS1—lymph node—thymus cancer	0.000646	0.0109	CbGeAlD
